Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 03835L504

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 0.00 · Class: 0%

  • Point72 Capital Advisors, Inc.

    Shares: 0.00 · Class: 0%

  • Steven A. Cohen

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001127
Form type
SCHEDULE 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub